Medication used to treat heart failure recalled nationwide

A nationwide recall has been issued in the United States for Corlanor, generically known as ivabradine, a medication used to reduce the risk of hospitalization in patients with heart failure. The FDA recall alert says nearly 1 million bottles may contain a foreign substance, prompting the action. The recall affects at least 934,577 bottles of 5 mg tablets of Corlanor manufactured in Italy. Amgen, Inc. is initiating the recall voluntarily. Corlanor is prescribed for adults with chronic heart failure to lower the risk of hospitalization due to worsening conditions, and it is also used in children aged 6 months and older with stable heart failure symptoms caused by an enlarged heart, according to the Mayo Clinic. The recall began on June 4 and has been classified as a Class II recall, meaning use or exposure may cause temporary or reversible adverse health effects.